ON-POINT: COVID-19 and monkeypox situation domestically and worldwide
Updated: 2022-06-28 05:26:55 KST
It's time for On-Point, where we speak to experts to delve deeper into some of the key issues in the spotlight right now. Daily COVID-19 numbers are down, and most importantly, the number of critically ill patients are down as well. But despite the decline, we have a new concern: monkeypox.
That's right. And with South Korea also reporting its first case of monkeypox last week, how worried should we be? To find out, we connect with Ben Cowling, Chair Professor of Epidemiology at the University of Hong Kong.
First off, let's start with some COVID-19 related issues. The number of critically ill patients are significantly down compared to the height of the Omicron wave. Are the treatments working or is Omicron that much less severe than other variants?
There's rising concern about waning immunity for those that already been infected early on, or were vaccinated more than 6 months ago. What does the data say regarding how long immunity lasts, if you've been infected, and if you've been vaccinated?
Let's delve into the monkeypox issue now. We've seen our first case of the virus here in the country. How severe are the symptoms of monkeypox and how is it treated?
Can monkeypox only be spread through skin-to-skin contact, or can someone be infected if an infected person touches something, and a non-infected person touches that, as well?
Thank you for insights. Looking forward to speaking to you again.